Search SAMHSA Publications and Digital Products
Store Facets Summary
Main page content
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: January 2021
This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.
Published: December 2015
This Korean-language brochure describes the stages of recovery from people living with substance use disorders and what to expect after leaving detoxification services. It offers guidance on adjusting to sobriety and long-term recovery. The brochure also discusses legal issues and lists resources.
Published: November 2014
Describe las etapas de la recuperación del abuso de drogas y el alcohol y lo que se puede esperar después de terminar el proceso de desintoxicación. Ofrece consejos para ajustarse a la sobriedad después de la desintoxicación y a través del proceso de recuperación a largo plazo. Habla sobre las implicaciones legales e incluye una lista de recursos adicionales.